Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levocetirizine Effect on Nasal Nitric Oxide in Perennial Allergic Rhinitis
NCT00894231Phase 4Completed
- Sponsor
- AAADRS Clinical Research Center
- Start
- Jan 2009
- Primary completion
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, triple-blind trial in perennial allergic rhinitis (PAR) comparing Placebo with Levocetirizine (2 arms). Primary endpoint: Change in Nasal Nitric Oxide at 2 weeks. Started Jan 2009; status: completed.
02
Drugs
levocetirizine
03
Conditions
perennial allergic rhinitis (PAR)
Beyond the preview
Go deeper on NCT00894231.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00894231.